Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P427: Development of an index that predicts escalation of therapy at an outpatient appointment in patients with known ulcerative colitis (UC)ECCO '18 Vienna
Year: 2018
Authors:

A. Walsh1*, P. Seeva1, C. Hinds2, V. Sexton3, O. Brain1, S. Keshav1, H. Uhlig1, J. Geddes3, G. Goodwin3, M. Peters4, G. Collins5, S. Travis1

1John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, UK, 2Big Data Institute, Oxford, UK, 3University of Oxford, Psychiatry Department, Oxford, UK, 4University of Oxford, Nuffield Department of Population Health, Oxford, UK, 5University of Oxford, Centre for Statistics in Medicine, Oxford, UK

P428: Pharmacist-led proactive therapeutic drug monitoring with infliximab (PROXIMO): Utility of and cost-saving associated with the use of a rapid assay for assessing drug levelECCO '18 Vienna
Year: 2018
Authors:

C. Rentsch1*, M. Sparrow2,3, M. Ward2,3, K. Taylor2,3, A. Friedman2,4, R. Luber2,3, H. Su2, R. Hopkins1, B. Head-on2, M. Dooley2,3, P. Gibson2,4

1Alfred Health, Pharmacy, Melbourne, Australia, 2Alfred Health, Gastroenterology, Melbourne, Australia, 3Monash University, Centre for the Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Melbourne, Australia, 4Monash University, Department of Medicine, Melbourne, Australia

P429: Robotic-assisted vs. laparoscopic proctectomy for inflammatory bowel disease: Results of the case-match comparison in single institutionECCO '18 Vienna
Year: 2018
Authors:

M.V. Marino1*, A. Glagoleva2

1Azienda Ospedaliera Villa Sofia-Cervello, Emergency and General Surgery, Palermo, Italy, 2P.L Shupyk National Medical Academy Of Postgraduate Education, Kyiv, Ukraine

P430: Distinct faecal bile acid profiles are associated with sustained remission following exclusive enteral nutrition (EEN) induction therapy in paediatric Crohn's diseaseECCO '18 Vienna
Year: 2018
Authors:

J. Connors1*, R. Bandsma2, B. MacIntyre1, S. Whitehouse1, A. Noble1, M. Rashid1, A. Otley1, J. Van Limbergen1

1IWK Health Centre, Pediatric Gastroenterology and Nutrition, Halifax, Canada, 2Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Canada

P431: Golimumab dried blood spot analysis (GOUDA): A prospective trial to validate golimumab concentration analysis using the dried blood spot methodologyECCO '18 Vienna
Year: 2018
Authors:

I. Detrez1*, E. Dreesen1, G. Van Assche2, S. Vermeire2, M. Ferrante2, A. Gils1

1KU Leuven, Leuven, Belgium, 2UZ Leuven, Leuven, Belgium

P432: Does medical acceleration improve long-term outcomes in ulcerative colitis patients who are in clinical remission but have endoscopic mucosal inflammation?ECCO '18 Vienna
Year: 2018
Authors:

J.Y. Chang*, J.H. Cheon, Y. Park, S.J. Park, T.-I. Kim, W.-H. Kim

Yonsei University College of Medicine, Department of Internal Medicine and Institute of Gastroenterology, Seoul, South Korea

P433: Faecal calprotectin is correlated to endoscopic disease activity at Week 16 in IBD patients on vedolizumab therapyECCO '18 Vienna
Year: 2018
Authors:

R.W.M. Pauwels*, A.C. De Vries, C.J. Van der Woude

Erasmus MC, Gastroenterology and Hepatology, Rotterdam, The Netherlands

P434: Remission induction in corticosteroid naive children and adolescents with active ulcerative colitis by adsorptive leucocytapheresis after failure of first-line medications: Results from routine clinical practiceECCO '18 Vienna
Year: 2018
Authors:

T. Tanaka*, M. Akagi, H. Goishi, T. Iiboshi, T. Kajihara, T. Miura

Akitsu Prefectural Hospital, Hiroshima, Japan

P435: Effectiveness of therapeutic drug monitoring of infliximab and adalimumab in inflammatory bowel disease patients. Systematic review and meta-analysisECCO '18 Vienna
Year: 2018
Authors:

P. Petryszyn*, L. Dybalski, K. Gola

Wroclaw Medical University, Clinical Pharmacology, Wroclaw, Poland

P436: Ileal pouch-anal anastomosis with fluorescence angiography: Initial experience and potential applicationECCO '18 Vienna
Year: 2018
Authors:

A. Spinelli1*, P.G. Kotze2, M. Carvello1, F. Di Candido1, N. Buchs3, F. Ris4

1Humanitas Research Hospital, Rozzano, Milan, Italy, 2Cajuru University Hospital, Catholic University of Paraná, Curitiba, Brazil, 3Geneva University Hospital, Geneva, Switzerland, 4Geneva University Hospital, Geneva, Switzerland

P437: Higher adalimumab maintenance regimens are more effective than standard maintenance doses in Crohn’s disease patients who have failed infliximabECCO '18 Vienna
Year: 2018
Authors:

N. Narula1*, T. Greener2, K. Boland2, A.H. Steinhart2, M. Silverberg2

1McMaster University, Gastroenterology, Hamilton, ON, Canada, 2Mount Sinai Hospital, Toronto, Canada

P438: Reinduction with ustekinumab in Crohn’s disease patients with a loss of response to treatmentECCO '18 Vienna
Year: 2018
Authors:

V. Heron1*, S. Restellini1,2, T. Bessissow1, C. Lemieux1, P. Lakatos1, G. Wild1, E. Seidman1, A. Bitton1, W. Afif1

1McGill University Health Centre, Department of Gastroenterology, Montreal, Canada, 2Geneva's University Hospitals and University of Geneva, Division of Gastroenterology and Hepatology, Geneva, Switzerland

P439: Monitoring inflammatory Bowel disease activity in a virtual biologic clinic: The effects of proactive therapeutic drug monitoring on patient reported outcome measuresECCO '18 Vienna
Year: 2018
Authors:

N. Mc Gettigan*, M. McNally, C. Deane, A. Keogh, R. Costello, E. Slattery

Galway University Hospital, Gastroenterology, Galway, Ireland

P440: Early changes in the pharmacokinetic profile of vedolizumab-treated patients with inflammatory bowel disease may predict response after dose optimisationECCO '18 Vienna
Year: 2018
Authors:

C. Gouynou1, L. Pouillon1,2*, H. Rousseau3, C. Zallot1, C. Baumann3, L. Peyrin-Biroulet1

1Nancy University Hospital, Department of Gastroenterology, Vandoeuvre-lès-Nancy, France, 2Imelda GI Clinical Research Centre, Department of Gastroenterology, Bonheiden, Belgium, 3Nancy University Hospital, Clinical Research Support Facility PARC, Vandoeuvre-lès-Nancy, France

P441: Higher education, professional occupation and upper socio-economic status is associated with lower adherence to medications in patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

S.K. Tomar1*, S. Kedia2, N. Singh1, A.D. Upadhyay3, S. Bopanna1, D. Yadav1, S. Goyal1, S. Jain1, G. Makharia1, V. Ahuja1

1All India Institute of Medical Sciences, Department of Gastroenterology and Human Nutrition, New Delhi, India, 2All India Institute of Medical Sciences, Gastroenterology, New Delhi, India, 3All India Institute of Medical Sciences, Department of Biostatistics, New Delhi, India

P442: The additional value of cytapheresis therapy in patients with severe ulcerative colitis treated with oral tacrolimusECCO '18 Vienna
Year: 2018
Authors:

S. Takahashi*, M. Colvin, J. Toyosawa, M. Ishida, T. Kagawa, S. Kuraoka, Y. Aoyama, K. Okamoto, I. Sakakihara, K. Izumikawa, K. Yamamoto, S. Tanaka, M. Matsuura, S. Ishikawa, M. Wato, T. Hasui, T. Inaba

Kagawa Prefectural Central Hospital, Department of Gastroenterology, Takamatsu, Kagawa, Japan

P443: Systematic analysis of annual health resource utilisation and costs in hospitalised inflammatory bowel disease patients in SwitzerlandECCO '18 Vienna
Year: 2018
Authors:

A. Schoepfer1*, S. Vavricka2, B. Bruengger3, O. Reich3, E. Blozik3, C. Bähler3

1Centre Hospitalier Universitaire Vaudois, Gastroenterology and Hepatology, Lausanne, Switzerland, 2University Hospital Zurich, Zurich, Switzerland, 3Helsana Health Insurance, Zurich, Switzerland

P445: Patients with active perianal fistulas have a reduced physical health compared with Crohn’s patients without perianal fistulasECCO '18 Vienna
Year: 2018
Authors:

M. van der Voorn1,2*, M. Barnhoorn1, S. van Erp1, P. Maljaars3, M. Rodriquez Girondo4, A. Kaptein3, A. van der Meulen - de Jong1

1Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, The Netherlands, 2HagaZiekenhuis, Gastroenterology and Hepatology, The Hague, The Netherlands, 3Leiden University Medical Center, Medical Psychology, Leiden, The Netherlands, 4Leiden University Medical Center, Medical Statistics, Leiden, The Netherlands

P446: Patient and public involvement in a clinical trial for perianal Crohn’s fistulaECCO '18 Vienna
Year: 2018
Authors:

K. Sahnan1*, A. Verjee2, S. Blackwell3, R. Sawyer2, S. Mannick4, M.J. Lee5, S.O. Adegbola1, P.J. Tozer1, N. Heywood6, A.L. Hart7, N.S. Fearnhead8

1St Mark's Hospital, Colorectal Surgery, London, UK, 2Patient representative, London, UK, 3Patient Representative, Liverpool, UK, 4Patient Representative, London, UK, 5Sheffield Teaching Hospitals NHS Trust, Northern General Hospital, Department of Colorectal Surgery, Sheffield, UK, 6University Hospital South Manchester, Department of Colorectal Surgery, Manchester, UK, 7St Mark’s Hospital, IBD/Physiology, London, UK, 8Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Department of Colorectal Surgery, Cambridge, UK

P447: Infliximab trough levels are decreasing overtime in patients with inflammatory bowel disease on maintenance treatment with infliximabECCO '18 Vienna
Year: 2018
Authors:

E. Orfanoudaki1*, M. Gazouli2, K. Foteinogiannopoulou1, E. Theodouraki1, E. Legaki2, I. Koutroubakis1

1University Hospital Heraklion, Department of Gastroenterology, Heraklion, Greece, 2University of Athens, School of Medicine, Department of Basic Medical Science, Laboratory of Biology, Athens, Greece